Cohort Studymoderate evidence
Contingency Management for Stimulant Use Disorder and Association With Mortality: A Cohort Study.
The American journal of psychiatry·November 1, 2025·PMID 40926572
Why it mattersStimulant overdose deaths are rising, and no FDA-approved medications exist for StUD. This is the first evidence linking CM—the most effective known treatment—to reduced mortality in real-world settings, highlighting its potential life-saving impact.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled